Search research articles
Contact Us
Filters
Showing results (31-40 of 86) with videos related to
Page
of 9
Sort By:
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
November 21, 2001
Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade
P N Kim, E Jonasch, B C Mosterman, et al.
Blood
|
August 15, 1995
Interleukin-6-associated anemia: determination of the underlying mechanism
M B Atkins, K Kappler, J W Mier, et al.
Pathology and Immunopathology Research
|
January 1, 1988
Toxicity of immunotherapy with interleukin-2 and lymphokine-activated killer cells
J W Mier, F R Aronson, R P Numerof, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1988
IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury
F R Aronson, P Libby, E P Brandon, et al.
The Journal of Biological Chemistry
|
April 15, 1991
Biosynthesis and post-translational modification of CD6, a T cell signal-transducing molecule
J A Swack, J W Mier, P L Romain, et al.
Cytokine
|
November 1, 1992
Suppression of IL-2-induced SAA gene expression in mice by the administration of an IL-1 receptor antagonist
R P Numerof, J D Sipe, E G Trehu, et al.
Critical Care Medicine
|
November 1, 1995
Effects of malignancy and interleukin-2 infusion on gut macromolecular permeability
C M Ryan, M B Atkins, J W Mier, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1993
Possible myocardial toxicity associated with interleukin-4 therapy
E G Trehu, J M Isner, J W Mier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1982
Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+
A M Krensky, C S Reiss, J W Mier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1980
T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor
B J Poiesz, F W Ruscetti, J W Mier, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 86) with videos related to
Sort By:
Page
of 9
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
November 21, 2001
Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade
P N Kim, E Jonasch, B C Mosterman, et al.
Blood
|
August 15, 1995
Interleukin-6-associated anemia: determination of the underlying mechanism
M B Atkins, K Kappler, J W Mier, et al.
Pathology and Immunopathology Research
|
January 1, 1988
Toxicity of immunotherapy with interleukin-2 and lymphokine-activated killer cells
J W Mier, F R Aronson, R P Numerof, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1988
IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury
F R Aronson, P Libby, E P Brandon, et al.
The Journal of Biological Chemistry
|
April 15, 1991
Biosynthesis and post-translational modification of CD6, a T cell signal-transducing molecule
J A Swack, J W Mier, P L Romain, et al.
Cytokine
|
November 1, 1992
Suppression of IL-2-induced SAA gene expression in mice by the administration of an IL-1 receptor antagonist
R P Numerof, J D Sipe, E G Trehu, et al.
Critical Care Medicine
|
November 1, 1995
Effects of malignancy and interleukin-2 infusion on gut macromolecular permeability
C M Ryan, M B Atkins, J W Mier, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1993
Possible myocardial toxicity associated with interleukin-4 therapy
E G Trehu, J M Isner, J W Mier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1982
Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+
A M Krensky, C S Reiss, J W Mier, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 1, 1980
T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor
B J Poiesz, F W Ruscetti, J W Mier, et al.
Page
of 9